Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-09

Clinical Trial Update: Dexmedetomidine Infusion on Intraoperative Propofol,Fentanyl Requirements in Spine Surgery for Pediatric Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial investigating whether dexmedetomidine infusion reduces intraoperative propofol and fentanyl requirements in pediatric spine cancer surgery under a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Children's Cancer Hospital Egypt 57357 | Conditions: Spine Cancer, Anesthesia | Phase 3 | Status: UNKNOWN